Optical breast imaging developer DOBI Medical International said it expects to deliver between 10 and 15 of its ComfortScan systems to select international markets during its fiscal 2004.
In 2005, DOBI said that it expects to ship a minimum of 60 ComfortScan systems to select international markets. Revenue is expected to reach approximately $5.9 million, with a net loss of approximately $4.4 million.
DOBI said it plans to start patient clinical trials of ComfortScan in September, marking the final step in its pre-market approval (PMA) application to the Food and Drug Administration.
By AuntMinnie.com staff writersJuly 29, 2004
Related Reading
DOBI, BioTech ink distribution deal, July 15, 2004
DOBI inks deal for India sales, June 23, 2004
DOBI reaches agreement with FDA, June 8, 2004
DOBI adds industry veterans, March 31, 2004
DOBI inks South America distribution deal, January 16, 2003
Copyright © 2004 AuntMinnie.com
